ADDIS ABABA, Ethiopia- The CEO of Kenya BioVax Institute Limited, Dr Michael Lusiola, is participating in this year’s International Conference on Innovation, Intellectual Property and Technology Transfer in Africa’s Pharmaceutical Sector. Hosted by African Pharmaceutical Technology Foundation (APTF), the two-day conference will facilitate conversations on sustaining the momentum of promoting innovation, intellectual property, and technology transfer to strengthen Africa’s pharmaceutical sector. Speakers and participants will be able to deliberate on suitable ways to meet domestic needs for pharmaceutical production and supply to better prepare for the next generation of epidemics and pandemics.
Some of the Conference Themes that participants are focusing on are Technology gaps and innovation capacity in Africa’s public sector pharmaceutical R&D, Technology gaps and innovation capacity in Africa’s private sector, Intellectual property rights and pharmaceutical markets in Africa, Innovative financing models to develop Africa’s pharmaceutical R&D ecosystem, New development-centered approaches to build Africa’s domestic production ecosystem, Technology transfer (with a focus on the Best practice studies and normative frameworks), Regulating Africa’s pharmaceutical sector and Market shaping, pooled procurement and trade incentives for Africa’s pharmaceutical sector.
